- Report
- July 2025
- 235 Pages
Global
From €4233EUR$4,799USD£3,709GBP
- Report
- May 2025
- 473 Pages
Global
From €4233EUR$4,799USD£3,709GBP
- Report
- April 2025
- 550 Pages
Global
€2602EUR$2,950USD£2,280GBP
- Report
- September 2025
- 393 Pages
Global
From €5139EUR$6,030USD£4,350GBP
- Report
- March 2025
- 367 Pages
Global
From €5139EUR$6,030USD£4,350GBP
- Report
- August 2025
- 383 Pages
Global
From €4366EUR$4,950USD£3,825GBP
- Report
- December 2024
- 646 Pages
Global
From €4366EUR$4,950USD£3,825GBP
- Report
- October 2025
- 127 Pages
Global
From €4101EUR$4,650USD£3,593GBP
- Report
- November 2025
- 157 Pages
Global
From €4101EUR$4,650USD£3,593GBP
- Report
- March 2025
- 209 Pages
Global
From €4101EUR$4,650USD£3,593GBP
- Report
- May 2025
- 170 Pages
Global
From €4101EUR$4,650USD£3,593GBP
- Report
- October 2025
- 150 Pages
Global
From €5248EUR$5,950USD£4,598GBP
- Report
- October 2025
- 120 Pages
Global
From €5248EUR$5,950USD£4,598GBP
- Report
- October 2025
- 120 Pages
Global
From €5248EUR$5,950USD£4,598GBP
- Report
- September 2025
- 120 Pages
Global
From €5248EUR$5,950USD£4,598GBP
- Report
- June 2025
- 120 Pages
Global
From €5248EUR$5,950USD£4,598GBP
- Report
- October 2025
- 150 Pages
Global
From €5248EUR$5,950USD£4,598GBP
- Report
- October 2025
- 120 Pages
Global
From €5248EUR$5,950USD£4,598GBP
- Report
- June 2025
- 136 Pages
Global
From €5248EUR$5,950USD£4,598GBP
- Report
- March 2025
- 225 Pages
Global
From €5248EUR$5,950USD£4,598GBP

The Protein Drugs market is a subset of the larger Drug Discovery industry. It focuses on the development of drugs that are based on proteins, such as monoclonal antibodies, cytokines, and growth factors. These drugs are used to treat a variety of diseases, including cancer, autoimmune disorders, and infectious diseases. Protein drugs are typically developed through recombinant DNA technology, which involves the manipulation of genetic material to create a desired protein.
The Protein Drugs market is highly competitive, with many companies vying for a share of the market. Companies in the market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are engaged in research and development of new protein drugs, as well as the marketing and distribution of existing drugs. Show Less Read more